Hourly refreshSat, Sep 19, 2026

Press Release Database

Recent press releases, indexed by topic.
Topic

Healthcare

7,668 press releases indexed under healthcare.

AllFinanceCryptoAISaaSHealthcareReal EstateEnergyRetailAutomotiveGamingMediaEducation
DownloadExcelTXT
SaaS · Healthcare

Medical Care Technologies (OTCID:MDCE) Advances StrainScan Pro Into ...

(PR-inside.com) After Agricultural Demos, Company Maps a Parallel Path for Custom Kitchen Demonstrations Across Commercial Kitchens and Multi-Unit Operators MESA, AZ / ACCESS Newswire / September 11, 2026 / Medical Care Technologies Inc. (OTCID:MDCE) today announced further progress on StrainScan Pro's foodservice application, advancing the platform from market positioning into a custom demonstration path for commercial kitchens and multi-unit operators. The platform is live at https://strainscanpro.com . Foodservice has already been identified as a core StrainScan Pro vertical alongside agriculture. The Company is now taking the same next step it recently took on the farm side: putting the software in front of operators. After ..

Sep 11 · 12:57PR-Inside
Healthcare

Medical Care Technologies (OTCID:MDCE) Advances StrainScan Pro Into a Second Major Vertical: The $4 Trillion Foodservice Market

After Agricultural Demos, Company Maps a Parallel Path for Custom Kitchen Demonstrations Across Commercial Kitchens and Multi-Unit Operators

Sep 11 · 12:57Newswire.com
Healthcare · Education

Korea University Study Uncovers How mRNA Vaccination May Broaden Flu Antibody Responses

New study finds that mRNA vaccination sustained influenza-specific germinal-center activity for up to six months in some participants SEOUL, South Korea, Sept. 11, 2026 /PRNewswire/ -- Influenza remains a major global health challenge as continual antigenic drift can limit the breadth and...

Sep 11 · 12:48PR Newswire
Finance · Healthcare

Moleculin Presentation from H.C. Wainwright Conference Now Available On-Demand

HOUSTON, Sept. 11, 2026 (GLOBE NEWSWIRE) -- Moleculin Biotech, Inc. , (Nasdaq: MBRX) (“Moleculin” or the “Company”), today announced that its pre-recorded presentation from the H.C. Wainwright 28th Annual Global Investment Conference is now available for on-demand viewing here .

Sep 11 · 12:30GlobeNewswire
Finance · SaaS

Quantum BioPharma Ltd. (NASDAQ: QNTM) Filling Key Gap in MS Treatment, Cleared by FDA to Launch Historic Trials

NEW YORK, Sept. 11, 2026 (GLOBE NEWSWIRE) -- via BioMedWire — Quantum BioPharma Ltd. (NASDAQ: QNTM) today announces its placement in an editorial published by BioMedWire (BMW), one of 75+ brands within the Dynamic Brand Portfolio @ IBN ( InvestorBrandNetwork ) , a specialized communications platform with a focus on financial news and content distribution for private and public companies and the investment community.

Sep 11 · 12:30GlobeNewswire
Healthcare

Red White & Bloom Brands Expands Into Europe with Strategic Cannabis Transaction

Transaction Establishes RWB in Germany and the United Kingdom, Two of Europe’s Most Important Medical Cannabis Markets

Sep 11 · 12:30GlobeNewswire
Finance · Healthcare

Elanco Confirms Date and Conference Call for Third Quarter 2026 Financial Results Announcement

INDIANAPOLIS, Sept. 11, 2026 /PRNewswire/ -- Elanco Animal Health Incorporated (NYSE: ELAN) will announce its third quarter 2026 financial results on Friday, November 6, 2026. Elanco will also conduct a conference call on that day with the investment community and media to further detail...

Sep 11 · 11:58PR Newswire
Healthcare

Handa Oncology Receives FDA Final Approval for OMCAZIO(TM) (cabozantinib) ...

(PR-inside.com) OMCAZIO approved for administration without regard to food, removing strict fasting requirements for cabozantinib patients SAN JOSE, CA AND TAIPEI, TW / ACCESS Newswire / September 11, 2026 / Handa Pharmaceuticals, Inc. ("Handa" or the "Company") (TSE:6620) announced that the U.S. Food and Drug Administration ("FDA") has granted final approval to OMCAZIO™ (cabozantinib) capsules, the laurylsulfate salt formulation of cabozantinib developed by the Company's U.S. subsidiary, Handa Oncology, LLC. The action converts Handa's prior tentative approval to final approval and authorizes OMCAZIO for commercialization in the United States. "Final approval from the FDA is a landmark milestone for Handa and reflects our ..

Sep 11 · 11:30PR-Inside
Healthcare

Frost & Sullivan presents the "GLOBAL GENE THERAPY CRDMO TECHNOLOGY INNOVATION LEADERSHIP AWARD" to PackGene Biotech Inc.

Shanghai, China--(Newsfile Corp. - September 11, 2026) - On August 4, the 20th Frost & Sullivan Global Growth, Innovation and Leadership (GIL) Summit and the 5th New Investment Event (the "2026 Frost & Sullivan New Investment Event") officially opened at Jing An Shangri-La, Shanghai.In conjunction with the Summit, the Celebratory Banquet for the 65ᵗʰ Anniversary of Frost & Sullivan Global and the 20ᵗʰ Anniversary of the GIL Summit in China was held, where the 2026 Frost & Sullivan Global Awards...

Sep 11 · 11:28mlpr-newsfile
Healthcare

Pharmaceutical Packaging Equipment Market Outlook Strengthened by Digitalization

A pharmaceutical product cannot reach the patient safely through formulation alone. Before a tablet, vaccine, biologic, or injectable reaches the market, it must pass through [read full press release...]

Sep 11 · 11:25Express Press Release
Finance · Healthcare

Fractyl Health, Inc. (GUTS) Lawsuit - Investors Urged to Contact Levi ...

(PR-inside.com) NEW YORK, NY / ACCESS Newswire / September 11, 2026 / Levi & Korsinsky, LLP announces that a securities class action lawsuit has been filed on behalf of investors who purchased or otherwise acquired Fractyl Health, Inc. (NASDAQ:GUTS) securities. If you suffered a loss on your Fractyl Health, Inc. investment and would like to explore a potential recovery under the federal securities laws, Learn about Fractyl Health, Inc. Class Action or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call (212)363-7500 to speak to our team of experienced shareholder advocates. THE LAWSUIT: A class action securities lawsuit was filed against ..

Sep 11 · 11:25PR-Inside
Finance · Healthcare

enVVeno Medical Presentation from H.C. Wainwright Conference Now Available ...

(PR-inside.com) Access the video webcast here IRVINE, CA / ACCESS Newswire / September 11, 2026 / enVVeno Medical Corporation (NASDAQ:NVNO) ("enVVeno Medical" or the "Company"), today announced that its pre-recorded presentation from the H.C. Wainwright 28th Annual Global Investment Conference is now available for on-demand viewing here. The presentation, featuring Robert Berman, Chief Executive Officer of enVVeno Medical, provides an overview of the Company and its innovative enVVe® System, as well as recent corporate and clinical developments. The on-demand presentation is available for viewing beginning today, September 11, 2026, at 7:00 a.m. ET, and can be accessed through the Events page on the Investors ..

Sep 11 · 11:02PR-Inside
← Prev123639Next →